In just one year, the healthcare supply chain leader achieves 80% YoY growth, ₹582 crore (including GMV) topline in Q2, and turns EBITDA positive through disciplined execution and strategic realignment.One year ago, Medikabazaar embarked on a strategic path of hypergrowth with a clear focus on profitability.